When the Data Lies, the Autopsy Tells the Truth.

When three seemingly unrelated sudden-cardiac-arrest victims arrive at the San Francisco Medical Examiner's office within forty-eight hours, Chief Deputy Medical Examiner Dr. Lucas Keller detects a subtle, anomalous cardiac biomarker pattern that official hospital toxicology reports missed.

All three victims were secretly enrolled in Phase II clinical trials for a revolutionary neuro-oncology compound engineered by an elite biotech firm headquartered in the foggy industrial waterfront of South San Francisco. But according to the FDA trial registry, none of these patients ever existed—they are "ghost subjects" deleted from the statistical cohort before trial audits.

Partnering with investigative journalist Sloane Mercer, Keller follows the paper trail from waterfront autopsy suites across the Bay Bridge to high-security computational pharmacology labs in Emeryville. As institutional pressure mounts to close the autopsies and lethal enforcement teams close in, Keller must risk his license, his sanity, and his life to bring the truth to light.

Key Series Features:

• Authentic Medical & Autopsy Tradecraft: Real forensic pathology protocols, PEA rhythm analysis, toxicology assays, and hospital compliance bureaucracy.
• Atmospheric San Francisco & East Bay Setting: Cold marine fog rolling across the Golden Gate, shadowy waterfront container docks, and high-tech biotechnology glass towers.
• High-Stakes Procedural Pacing: Fast, smart, forensic investigation without melodrama—just clinical intellect versus ruthless corporate power.